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Abstract
Background: Ischemia-reperfusion (I/R) causes a dramatic reprogramming of cell metabolism
during liver transplantation and can be linked to an alteration of the phosphorylation level of several
cellular proteins. Over the past two decades, it became clear that tyrosine phosphorylation plays
a pivotal role in a variety of important signalling pathways and was linked to a wide spectrum of
diseases. Functional profiling of the tyrosine phosphoproteome during liver transplantation is
therefore of great biological significance and is likely to lead to the identification of novel targets
for drug discovery and provide a basis for novel therapeutic strategies.
Results:  Using liver biopsies collected during the early phases of organ procurement and
transplantation, we aimed at characterizing the global patterns of tyrosine phosphorylation during
hepatic I/R. A proteomic approach, based on the purification of tyrosine phosphorylated proteins
followed by their identification using mass spectrometry, allowed us to identify Nck-1, a SH2/SH3
adaptor, as a potential regulator of I/R injury. Using immunoblot, cell fractionation and
immunohistochemistry, we demonstrate that Nck-1 phosphorylation, expression and localization
were affected in liver tissue upon I/R. In addition, mass spectrometry identification of Nck-1 binding
partners during the course of the transplantation also suggested a dynamic interaction between
Nck-1 and actin during I/R.
Conclusion: Taken together, our data suggest that Nck-1 may play a role in I/R-induced actin
reorganization, which was previously reported to be detrimental for the hepatocytes of the
transplanted graft. Nck-1 could therefore represent a target of choice for the design of new organ
preservation strategies, which could consequently help to reduce post-reperfusion liver damages
and improve transplantation outcomes.
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Background
Protein phosphorylation is considered to be one of the
major determinants regulating a large spectrum of biolog-
ical processes [1]. It is a key reversible modification occur-
ring mainly on serine, threonine and tyrosine residues, by
acting as a switch to turn "on" or "off" a protein activity or
a cellular pathway [2]. Although far less frequent than ser-
ine/threonine phosphorylation [3], tyrosine phosphor-
ylation plays a key role in regulating many different
processes in eukaryotic organisms, such as growth or cell
cycle control, differentiation, cell shape and movement,
gene transcription, synaptic transmission and insulin
action [4]. Phosphotyrosine (PY) residues are recognized
by specialized binding domains on other proteins such as
Src Homology 2 (SH2), PY interaction domains (PID) or
PY binding domains (PTB) [5], and such interactions are
used to initiate and promote intracellular signalling. Tyro-
sine phosphorylation therefore plays a prominent role in
signal transduction, but yet, these signalling pathways
have been difficult to identify, in part because of their
complexity and in part because of low cellular levels of
tyrosine phosphorylation.
Recent advances, including the availability of the com-
plete human genome sequence [6], have set the stage for
comprehensive or global proteomic analyses. At the same
time, mass spectrometry was emerging as a reliable and
sensitive tool for protein identification and protein phos-
phorylation site determination [7] and now represents a
method of choice for the large scale analysis of protein
phosphorylation [3]. After affinity-based enrichment of
tyrosine phosphorylated proteins using specific anti-PY
antibodies, phosphorylation analysis by mass spectrome-
try is generally accomplished in a two-step process. Pro-
teins of interest are proteolytically digested, usually with
trypsin, and the resulting peptides are analyzed to deter-
mine those which are phosphorylated. Separation of tryp-
tic peptides using liquid chromatography (LC) is an
efficient strategy to decrease sample complexity. Subse-
quently, peptides are further analyzed by tandem mass
spectrometry (MS/MS), i) to identify the corresponding
proteins and ii) to determine the precise location of the
phosphorylation site(s). Phosphopeptides can be identi-
fied simply by examination of the list of observed peptide
masses for mass increases of 80 Da (the added mass of the
phosphate group) compared with the list of expected pep-
tide masses.
Ischemia/reperfusion (I/R) constitutes a major injury in a
variety of circumstances including as myocardial infrac-
tion, cerebral ischemia, stroke, hemorrhagic shock and
organ transplantation [8]. During liver transplantation,
donor organs experience some degree of preservation
injury which is a cold I/R injury. Indeed, cold storage of
the organ slows down metabolic processes that may lead
to cell death and organ failure during the ischemic phase.
It represents therefore one of the most fundamental com-
ponent of successful organ preservation during transplan-
tation, but also leads to specific secondary damages [9]
The magnitude of preservation injury is a critical determi-
nant for the success of liver transplantation. However,
despite an intense investigative effort, the global, multi-
factorial and complex cell response initiated upon
ischemia and reperfusion remains unclear.
In an attempt to uncover novel aspects of this intricate
response, we have used a proteomic approach to charac-
terize the cellular pathways regulated upon I/R during
human liver transplantation. This led us to identify the
adaptor protein Nck-1 as a major PY-containing protein
whose phosphorylation level is regulated upon I/R. More-
over, we show that Nck-1 tyrosine phosphorylation coin-
cides with changes in its sub-cellular localization and
association with actin cytoskeleton. Our data provide the
first evidence for Nck-1 tyrosine phosphorylation upon I/
R in human liver and suggest that this protein may repre-
sent an important player in hepatocytes stress response.
Results
Identification of tyrosine-phosphorylated proteins upon I/
R
To better characterize the signalling pathways activated
during human liver transplantation, we aimed to identify
phosphotyrosine (PY) containing proteins whose phos-
phorylation was regulated upon I/R. To this end, we used
liver biopsies collected as described in Figure 1A. Protein
extracts (I0, I10, I60 corresponding to 0, 10 and 60 min
ischemia and R0, R10, R60 corresponding to 0, 10 and 60
min reperfusion, respectively) were prepared as described
in the Methods section and processed for immunoblot
analyses using anti-PY antibodies. This allowed us to
obtain a global tyrosine phosphorylation pattern during
I/R (Figure 1B). Although, no significant change was
observed for the large majority of the proteins protein
detected, a major protein with a molecular weight of
approximately 50 kDa was subjected to a dramatic change
in its tyrosine phosphorylation status during both phases
of the transplantation. An important tyrosine phosphor-
ylation increase during the ischemic phase and a consecu-
tive decrease during reperfusion were observed. In order
to identify PY-containing proteins during the two phases
of the transplantation, proteins extracts from biopsies col-
lected at 60 min ischemia (I60) and 60 min reperfusion
(R60) were chromatographed on anti-PY antibodies cou-
pled to agarose beads as schematically represented in Fig-
ure 2A. Proteins were then eluted, resolved by 1D SDS-
PAGE and stained using G250 Coomassie Blue (Figure
2B). Noteworthy, a major Coomassie Blue stained band
in the I60 tyrosine phosphorylated fraction was no longer
detectable in the R60 fraction, indicating that this ~50Proteome Science 2007, 5:1 http://www.proteomesci.com/content/5/1/1
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kDa band may contain PY proteins specific to the
ischemic phase. This protein may most likely correspond
to the major protein detected in Figure 1B. Each band vis-
ualized on the gel was then excised, trypsin digested and
the resulting peptides analyzed using Liquid Chromatog-
raphy – ElectroSpray Ionization – quadrupole Time of
Flight – tandem Mass Spectrometry (LC-ESI-QToF) MS/
MS as described in the Methods section. The proteins
identified are listed in Tables 1 (I60) and 2 (R60) and rep-
resented after classification into functional families
according to their GO (Gene Ontology) annotation (Fig-
ure 2C). We identified only 7 proteins in the 60 min
ischemia fraction (Table 1). Interestingly, the ~50 kDa
band disappearing between I60 and R60 was reproducibly
identified as the SH2/SH3 containing adaptor protein Nck-
1 (Table 1). Besides Nck-1, which represented the only
signalling component of this fraction, the 6 other proteins
identified were composed of abundant proteins involved
in liver metabolic functions (energy metabolism and
detoxification) and of blood proteins involved in trans-
port (Table 1 and Figure 1C, left panel). These 6 proteins
were also found in the 60 min reperfusion fraction (Tables
1 and 2), suggesting that they may either represent con-
taminants or be constitutively tyrosine phosphorylated.
Interestingly, a larger data set of 37 proteins was identified
for the 60 min reperfusion time point (Table 2 and Figure
1C, right panel). In addition to hepatocytes to proteins
involved in liver metabolism (energy metabolism: 16%
and detoxification: 8%) and blood proteins (blood coag-
ulation: 5%, transport: 11%), a large proportion (33%) of
these proteins were involved in protein synthesis (mainly
ribosomal proteins). We also identified structural compo-
nents of the cytoskeleton (16%) and proteins involved in
nucleobase metabolism (8%), as well as 1 unknown pro-
tein. Although the computational prediction of serine,
threonine and tyrosine phosphorylation using the Net-
Phos software indicated potential tyrosine phosphoryla-
tion sites for the large majority of the proteins identified
(Table 1 and 2), only 3 of these proteins had been previ-
ously reported as tyrosine phosphorylated: the alpha
chain of tubulin, vimentin and the 60S ribosomal protein,
L8 (Table 2).
Validation of Nck-1 tyrosine phosphorylation upon I/R
The SH2/SH3 containing adaptor Nck-1 has been linked to
the regulation of multiple intracellular signal transduc-
tion events [10] with significant contribution to actin
cytoskeleton remodelling. Consequently, Nck-1 could
represent a critical target during I/R as actin cytoskeleton
was previously reported to be subjected to major struc-
tural changes in livers subjected to I/R [11]. Four peptides
were specifically attributed to Nck-1 (underlined on Nck-
1 sequence, Figure 3A) in the 60 min ischemia fraction.
The MS/MS spectrum corresponding to a peptide specific
of Nck-1 is presented for reference (Figure 3B). Remarka-
bly, besides the fact that the band corresponding to Nck-1
could not be detected by Coomassie Blue staining of the
anti-PY purified fractions after 60 min of reperfusion (Fig-
ure 2B), Nck-1 was no longer identified in the anti-PY
binding fraction after 60 min of reperfusion (Table 2),
thus suggesting that Nck-1 may be either specifically tyro-
sine phosphorylated during the ischemic phase or associ-
ated to a phosphotyrosine-containing complex through
its SH2 domain.
Nck-1 has previously been reported to be tyrosine phos-
phorylated in response to treatment with growth factors
[12,13], but no information relative to the precise PY site
is yet available in the literature. Noteworthy, the NetPhos
software predicted four potential tyrosine phosphoryla-
tion sites within the Nck-1 sequence; two of them being
located within MS identified non phosphorylated pep-
tides (Figure 3C and red bold on Nck-1 sequence, Figure
3A). We experimentally confirmed that Nck-1 was indeed
tyrosine phosphorylated by Nck-1 immunoprecipitation
followed by immunoblot using anti-PY antibodies. A PY
containing Nck-1 protein was detected as increasing dur-
ing the first hour of ischemia, and decreasing during the
first hour of reperfusion (Figure 3D, top panel). This was
not due to major changes in the amount of Nck-1 protein
immunoprecipitated as indicated by the blot using anti-
Nck-1 antibodies (Figure 3D, bottom panel, and graph).
This pattern further confirms that the ~50 kDa protein
observed in Figure 1B may indeed represent Nck-1. This
result also validates both Nck-1 tyrosine phosphorylation,
as determined in our mass spectrometry analysis and the
relevance of our approach to identify tyrosine phosphor-
ylated proteins modulated during human liver transplan-
tation.
Nck-1 expression and sub-cellular localization in liver 
tissue upon I/R
To further characterize the functional relevance of Nck-1
tyrosine phosphorylation during human liver transplan-
tation, we first assessed the expression levels of Nck-1 in
the ischemic and reperfused livers using immunoblot
analysis (Figure 4A). We observed an increased expression
of Nck-1 during ischemia followed by a decrease during
reperfusion. We then investigated the in situ distribution/
localization of Nck-1 in liver during the different phases
of the transplantation. Tissue biopsies were homogenized
in the presence of 150 mM KCl. Particulate fractions were
partitioned by centrifugation as described in the Methods
section, and collected as P100 (insoluble pellet fraction)
and S100 (soluble fraction). Interestingly, Nck-1 showed
a decreased association with the insoluble components
during the course of ischemia, whereas this pattern was
reversed upon reperfusion (Figure 4B, upper panel). This
observation correlates with the detection of increased
amounts of this protein in the soluble fractions uponProteome Science 2007, 5:1 http://www.proteomesci.com/content/5/1/1
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ischemia followed by a decrease upon reperfusion (Figure
4B, lower panel). These data suggest that Nck-1 is sub-
jected to severe localization changes upon I/R in the liver.
Immunohistochemical studies on liver sections upon I/R
revealed that Nck-1 localized in hepatocytes' cytoplasm
under basal conditions and concentrated at the cell
periphery after 1 h of ischemia (Figure 4C, I60). This phe-
nomenon appeared to be reversed upon reperfusion (Fig-
ure 4C, R60). Interestingly, Nck-1 followed the same
redistribution that we previously observed for F-actin
[11]. Since Nck-1 is known to link tyrosine phosphoryla-
tion induced by extracellular signals to downstream regu-
lators of actin dynamics [14], this protein may therefore
serve to promote actin reorganization at hepatocytes'
periphery upon I/R.
Determination of Nck-1 interacting partners upon I/R
To better characterize the involvement of Nck-1 in actin
remodelling in livers subjected to I/R, we aimed at identi-
fying Nck-1 interaction partners during the course of
transplantation. To this end, GST Nck-1 pull-downs were
carried out using I0, I60, R0 and R60 protein extracts pre-
cleared with GST (see Methods). Nck-1 binders were
eluted, resolved by SDS-PAGE and the bands visualized
on Coomassie Blue stained SDS-PAGE gels were processed
for mass spectrometry analysis as represented in Figure
Biopsy collection and evaluation of global tyrosine phosphorylation patterns upon I/R Figure 1
Biopsy collection and evaluation of global tyrosine phosphorylation patterns upon I/R. A. Schematic representation 
of biopsy collection timing illustrating the surgical phases and corresponding liver injury. B. Representative immunoblot analysis 
of tyrosine phosphorylation on total fractions for 0, 10 and 60 min ischemia (I0, I10, I60) and 0, 10 and 60 min reperfusion (R0, 
R10, R60) liver protein extracts. N = 2 on 3 independent pools of 3 liver biopsy protein extracts.Proteome Science 2007, 5:1 http://www.proteomesci.com/content/5/1/1
Page 5 of 15
(page number not for citation purposes)
Identification of tyrosine phosphorylated proteins upon I/R Figure 2
Identification of tyrosine phosphorylated proteins upon I/R. A. Schematic representation of the approach used for 
tyrosine phosphorylated proteins identification. PY matrix: anti-phosphotyrosine antibodies coupled to agarose beads. B. Rep-
resentative SDS-PAGE experiment after tyrosine immunoprecipitation (Ip PY) of 60 min ischemia (I60) and 60 min reperfusion 
(R60) protein extracts. The band marked by an arrow has been further identified as the SH2/SH3 adaptor Nck-1. N = 1 on 2 
independent pools of 3 liver biopsy protein extracts. C. Pie-chart representation of the total number of proteins identified with 
a significant Mascot score by at least one unique peptide for the 60 min ischemia (I60, left panel) and the 60 min reperfusion 
(R60, right panel). The proteins were classified in functional families according to their GO (Gene Ontology) annotation.Proteome Science 2007, 5:1 http://www.proteomesci.com/content/5/1/1
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5A. No significant changes in proteins binding to GST
Nck-1 could be detected by Coomassie Blue staining (Fig-
ure 5B). However, besides the bait proteins (Nck-1 and
GST) and 9 proteins commonly identified for the 4 time
points (Figure 4C), we also identified Nck-1 interacting
proteins specific to I60 (11) or R0 (10) (see Additional
File 1). Although using this approach, we did not find any
of the proteins previously reported to interact directly
with Nck-1, we identified actin as a major Nck-1 binding
partner specific to the ischemic phase (after 60 min of
ischemia -I60- and just before reperfusion -R0-, but not
for the other time points). We believe that the absence of
known Nck-1 interactants in our list may result from their
generally low abundance which could then be masked by
the presence of abundant liver metabolism proteins or by
the fact that we are using an exogenous Nck-1 molecule
instead of the endogenous as a trap. The presence of actin
in association with Nck-1 during the ischemic phase,
however, correlates with our immunohistochemistry data
and, as a consequence, strengthens the hypothesis of Nck-
1 involvement of in ischemia-induced actin dynamics.
Discussion
Ischemia-reperfusion injury represents a major determi-
nant for the success of liver transplantation. Such a com-
plex and multifactorial cell response implies the concerted
activation of major signalling cascades [15]. Subse-
quently, regulation of I/R injury must involve critical
phosphorylation events, even though few of them have
been characterized to date [11,16-18]. Protein tyrosine
kinases and protein tyrosine phosphatases play a key role
in cell signalling, and the recent successes of specific tyro-
sine kinase inhibitors in cancer treatment [19] strongly
validate the clinical relevance of the research carried out
on tyrosine phosphorylation in various patho-physiolog-
ical contexts. Functional profiling of the tyrosine phos-
phoproteome during the course of liver transplantation
should very likely lead to the identification of novel tar-
gets for drug discovery and provide the basis for novel
molecular diagnostic approaches.
Analysis of the entire cellular phosphoprotein content,
the so-called phosphoproteome, is an attractive study sub-
ject since technical advances of mass spectrometry meth-
odologies can now lead to the accurate identification of
post-translational modifications in a global and compre-
hensive manner [3]. However, a major obstacle in the
study of phosphorylated proteins is that they comprise
only a small fraction of the total protein contained in a
cell lysate. Nevertheless, several studies based on anti-PY
immunoprecipitation prior to mass spectrometry identifi-
cation have been relatively effective at enriching and iden-
tifying even low-abundance tyrosine phosphorylated
proteins [20-22].
Using such an approach, we identified 7 proteins for the
60 min ischemia and 37 proteins for the 60 min reper-
fusion protein extracts (Figure 2). The fact that far fewer
proteins were identified after 60 min of ischemia can be
explained by the depletion of cellular ATP at this stage
[23]. This finding also correlates with our previously pub-
lished studies as i) we recently showed that the number of
Table 1: Anti-PY binding proteins – 60 min ischemia
Protein name Accession 
number¶
Mascot 
score
Sequence 
Coverage
Peptide 
number
Subellular 
Localization
Biological 
Function
Reported 
PY sites*
Predicted 
PY sites+
Serum albumin precursor P02768 410 22% 10 secreted transport none 108, 164, 
365, 476, 521
Carbamoyl-phosphate 
synthetase 1
Q5R206 298 4% 5 mitochondrion detoxification none 443, 634, 
768, 852, 
872, 957, 
959, 1032, 
1305, 1450
Dihydrolipoamide branched 
chain transacylase
P11182 196 14% 6 mitochondrion energy 
metabolism
none 36, 85, 130
Nck adaptor protein 1 P16333 164 11% 4 cytosol signalling none 13, 112, 268, 
339
Phosphoenolpyruvate 
carboxykinase
P35558 70 2% 1 mitochondrion energy 
metabolism
none 165, 279, 595
Enoyl-CoA hydratase P30084 62 2% 1 mitochondrion energy 
metabolism
none 35
Alcohol dehydrogenase 
[NADP+]
P14550 47 4% 2 cytosol detoxification none 49, 139, 240, 
324
Proteins identified in the 60 min ischemia and the 60 min reperfusion fractions are represented in italic.
¶ Database: SwissProt
*source: SwissProt and Human Protein Reference Database
+ source: NetPhos 2.0P
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Table 2: Anti-PY binding proteins – 60 min reperfusion
Protein name Accession 
number¶
Mascot 
score
Sequence 
Coverage
Peptide 
number
Subellular 
Localization
Biological 
Function
Reported 
PY sites*
Predicted PY sites+
Actin, cytoplasmic 2 P63261 664 42% 19 cytosol cytoskeleton none 108,164,365,476,521
Carbamoyl-phosphate synthetase 1 Q5R206 538 9% 11 mitochondrion detoxification none 443,634,768,852,872,957, 
959,1032,1305,1450
60S ribosomal protein L7 P18124 495 45% 10 cytosol-
nucleus
protein 
metabolism
none 51,155,159,182
Serum albumin precursor P02768 393 17% 8 secreted transport none 108,164,365,476,521
Alcohol dehydrogenase [NADP+] P14550 387 21% 8 cytosol detoxification none 49,139,240,324
Unknown (protein for MGC:22633) BC0223191 375 21% 8 unknown unknown none 14,341
Dihydrolipoamide branched chain transacylase P11182 349 17% 8 mitochondrion energy 
metabolism
none 36,85,130
Myosin heavy chain P13533 316 6% 7 cytosol cytoskeleton none 162,284,311,387,411,502, 
1377,1462,1490,1854
Protein disulfide isomerase-related protein Q14554 218 10% 3 ER protein 
metabolism
none 113,222,242,245,357,364, 488
60S ribosomal protein L6 Q02878 217 16% 4 cytosol-
nucleus
protein 
metabolism
none 68,72,239
60S ribosomal protein L13a P40429 210 27% 6 cytosol-
nucleus
protein 
metabolism
none 53,191
60S ribosomal protein L18 Q07020 175 24% 4 cytosol-
nucleus
protein 
metabolism
none 23,165
60S ribosomal protein L5 P46777 143 12% 3 cytosol-
nucleus
protein 
metabolism
none 29,30,43,48,144,182,218, 239, 252
Enoyl-CoA hydratase P30084 107 3% 2 mitochondrion energy 
metabolism
none 35
Very-long-chain acyl-CoA synthetase O14975 102 4% 2 ER detoxification none 81, 117, 261, 413, 460, 553, 610
Ku antigen, 70 kD NP0014602 102 4% 2 nucleus nucleobase 
metabolism
none 8, 30, 103, 361, 534, 559
Alpha-s1-casein P47710 102 10% 2 secreted transport none none
60S ribosomal protein L8 P62917 99 9% 3 cytosol-
nucleus
protein 
metabolism
132 none
40S ribosomal protein S4 P62701 94 4% 1 cytosol-
nucleus
protein 
metabolism
none 53, 120
Tubulin beta-1 chain Q9H4B7 92 8% 5 cytosol cytoskeleton none 55, 106, 222, 310
Complement C1q subcomponent subunit A P02745 86 6% 2 secreted blood 
coagulation
none 144
ATP-dependent RNA helicase A Q08211 83 3% 2 cytosol nucleobase 
metabolism
none 9,21,43,45,149,200,218,616,727748,11
55,1167,1189,1194, 1234P
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Galactokinase P51570 69 4% 1 cytosol energy 
metabolism
none 47,318
40S ribosomal protein S2 P60866 69 5% 2 cytosol-
nucleus
protein 
metabolism
none none
Beta-casein P05814 65 8% 2 secreted transport none 32,109
Phosphoenolpyruvate carboxykinase P35558 64 2% 1 mitochondrio
n
energy 
metabolism
none 165,279,595
40S ribosomal protein S3 P23396 64 3% 1 cytosol-
nucleus
protein 
metabolism
none 36,87,107, 67
Alpha-fetoprotein P02771 62 3% 1 secreted transport none 60, 151, 164, 426, 505, 521
ATP synthase beta chain P06576 50 3% 1 mitochondrio
n
energy 
metabolism
none 247, 418
Tubulin alpha-ubiquitous chain P68363 48 2% 1 cytosol cytoskeleton 272 210,224,399,432,451
Heterogeneous nuclear ribonucleoprotein 
AB
Q53F64 48 4% 1 cytosol-
nucleus
protein 
metabolism
none 235,272,307
Vimentin P08670 44 4% 2 cytosol cytoskeleton 116 10,29,52,275,290
Histone H1.3 P16402 44 11% 1 nucleus nucleobase 
metabolism
none none
Fibrinogen gamma chain P02679 42 3% 1 secreted blood 
coagulation
none 27,140,288,300,444,448
Alpha-tropomyosin P09493 39 1% 1 cytosol cytoskeleton none 60,162,214,221,261,267
ATP synthase alpha chain P25705 39 2% 1 mitochondrio
n
energy 
metabolism
none 299,476
60S ribosomal protein L4 P36578 37 3% 1 cytosol-
nucleus
protein 
metabolism
none 160
Proteins identified in the 60 min ischemia and the 60 min reperfusion fractions are represented in italic.
¶ Database: SwissProt except 1EMBL and 2GenBank
*source: SwissProt and Human Protein Reference Database
+ source: NetPhos 2.0
Table 2: Anti-PY binding proteins – 60 min reperfusion (Continued)Proteome Science 2007, 5:1 http://www.proteomesci.com/content/5/1/1
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proteins identified following IMAC-based enrichment
was also lower during ischemia [11] and ii) using anti-
phosphospecific antibodies, we demonstrated that for all
the proteins tested, phosphorylation levels decreased
upon ischemia and increased upon reperfusion [16]. This
was indicative of the occurrence of events which could
also be related to the depletion in high-energy phosphate
carriers.
In our study, most of the proteins identified are involved
in liver or blood basic metabolic functions. Consequently,
they are unlikely to represent critical signalling compo-
nents of I/R injury regulation but may rather indicate sig-
nificant modulation of the metabolic rates of liver tissues
upon transplantation. However, it is interesting to note
the presence of several ribosomal proteins, whose
involvement in protein translation could be linked to the
post-reperfusion restoration of protein biosynthesis as we
recently reported [16]. Moreover, the identification of two
subunits of ATP synthase can be correlated to the re-estab-
lishment of energy stores [23].
As illustrated in previously reported studies, our approach
did not lead to the identification of phosphorylation sites
[22,24]. This may be due to the low representation/
occurence of phosphotyrosine residues. Therefore, high
levels of non-phosphorylated peptide may mask the
detection of low-abundance phosphopeptides. In addi-
tion, the experimental conditions used for PY immuno-
precipitation can lead to the identification of non-
phosphorylated members of tyrosine phosphorylation-
dependent protein complexes. Finally, the liver is espe-
Nck-1 tyrosine phosphorylation status upon I/R Figure 3
Nck-1 tyrosine phosphorylation status upon I/R. A. Nck-1 sequence: peptides identified by mass spectrometry are rep-
resented underlined, predicted tyrosine phosphorylation site are in red bold. B. Representative MS/MS spectrum correspond-
ing to an Nck-1 specific peptide. C. Prediction of tyrosine-phosphorylation sites using the NetPhos software. D. Immunoblot 
analysis of Nck-1, using anti-Nck-1 antibody (Ib Nck-1) and Nck-1 tyrosine-phosphorylation status, using anti-phosphotyrosine 
antibody (Ib PY) following Nck-1 immunoprecipitation (Ip) on 60 min ischemia (I60) and 60 min reperfusion (R60) fractions. 
The band corresponding to Nck-1 is indicated by a black arrow. Immunoglobulins Heavy Chains (Ig HC) are indicated by a pur-
ple arrow. N = 2 on 3 independent pools of 3 liver biopsy protein extracts.Proteome Science 2007, 5:1 http://www.proteomesci.com/content/5/1/1
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Nck-1 expression and subcellular localization in human liver upon I/R Figure 4
Nck-1 expression and subcellular localization in human liver upon I/R. A. Immunoblot analysis of Nck-1 from total 
fractions of 0, 10 and 60 min ischemia (I0, I10, I60) and 0, 10 and 60 min reperfusion (R0, R10, R60) liver protein extracts 
(WCL: Whole Cell Lysate) normalized to Intersectin (Int). N = 2 on 3 independent pools of 3 liver biopsy protein extracts. B. 
Immunoblot analysis of Nck-1 from insoluble (P100 – lower panel) and soluble (S100 – upper panel) fractions obtained after 
centrifugation of liver biopsies homogenized in the presence of 150 mM KCl respectively normalized to Ribophorin (Rib) and 
Intersectin (Int) for the 3 ischemia time points – 0 (I0), 10 (I10) and 60 (I60) min and the 3 reperfusion time points 0 (R0), 10 
(R10) and 60 (R60) min. N = 2 on 3 independent pools of 3 liver biopsy protein extracts. C. Immunohistochemical detection of 
and Nck-1 on 8 µm liver tissue sections 0 and 60 min post-cold ischemia (I0 and I60) and 60 min post-reperfusion (R60). Cells 
were counterstained with haematoxylin (cells nuclei appear in blue). A representative experiment out of the 6 performed on 
independent ischemic and reperfused livers is shown. Scale bar = 10 µm.Proteome Science 2007, 5:1 http://www.proteomesci.com/content/5/1/1
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Determination of Nck-1 interactants by GST pull-down Figure 5
Determination of Nck-1 interactants by GST pull-down. A. Schematic representation of the approach used for tyro-
sine mass spectrometry identification of GST Nck-1 binding proteins. GST Nck-1 matrix: GST Nck-1 fusion protein coupled to 
sepharose beads. B. Representative SDS-PAGE experiment after GST Nck-1 pull-down of 0 (I0) and 60 min ischemia (I60) and 
0 (R0) and 60 min reperfusion (R60) protein extract. Bands corresponding to GST Nck-1 fusion protein and cleavage products 
(Nck-1 and GST) are marked by arrows. N = 1 on 2 independent pools of 3 liver biopsy protein extracts. C. Venn diagram 
representation of the proteins identified after mass spectrometry analysis of GST Nck-1 binding proteins.Proteome Science 2007, 5:1 http://www.proteomesci.com/content/5/1/1
Page 12 of 15
(page number not for citation purposes)
cially rich in certain classes of metabolic enzymes, which,
like for plasma proteomics [25] may mask the presence of
less abundant signalling components. Recently, several
teams partly overcame this problem by performing IMAC
enrichment in phosphopeptides after phosphotyrosine
containing proteins immunoprecipitation [26,27].
Although tyrosine phosphorylated protein identification
by mass spectrometry represents a significant advance in
the understanding of biological processes, we still believe
that experimental validation of the tyrosine phosphoryla-
tion status remains a necessary step to confirm identifica-
tions. Noteworthy, this step can be easily achieved using
specific anti-PY antibodies or in vitro phosphorylation
techniques [3].
Here, we experimentally confirmed Nck-1 tyrosine phos-
phorylation during the ischemic phase of liver transplan-
tation. In addition, we provide the first evidence that this
SH2/SH3 adaptor, which physically bridges PY-containing
regions to downstream components, can be itself tyrosine
phosphorylated under real biological conditions. Then,
we demonstrated that Nck-1 in vivo expression and sub-
cellular localization are affected in liver tissue during I/R,
correlating with its tyrosine phosphorylation status. We
observed that Nck-1 follows the same I/R-dependent sub-
cellular redistribution than that previously reported for
actin and IQGAP1. The characterization of Nck-1 interact-
ing partners also suggests an ischemia-induced associa-
tion of Nck-1 with actin.
In many reports, Nck-1 has been associated to actin
dynamics as a bridge between extracellular signals
through cell surface receptors to actin nucleation via the
WASP-Arp2/3 complex [28]. In views of our data and the
literature, Nck-1 could therefore represent a critical regu-
lator of ischemia-induced actin rearrangement at hepato-
cytes periphery. The fact that actin cytoskeleton
remodelling and the related maintenance of hepatocytes
canaliculi integrity were reported to have direct functional
implications on liver transplantation outcome especially
in term of i) bile secretion properties [29,30] and ii) cell's
tolerance to I/R stress [11] also suggests that Nck-1 could
represent a promising molecular target to reduce I/R-
induced liver damages.
Conclusion
In summary, this work consists in a proteomic analysis of
human liver biopsies combined with the targeted enrich-
ment of PY-containing proteins during different phases of
the transplantation. This approach led to the identifica-
tion of Nck-1. We confirm that Nck-1 is specifically tyro-
sine-phosphorylated during the ischemic phase and
correlate this observation with change in expression and
sub-cellular localization of this protein. Mass spectrome-
try identification of Nck-1 binding partners has allowed
us to formulate the hypothesis that Nck-1 could be related
to the ischemia-induced actin reorganization. The eluci-
dation of this molecular target may therefore on a longer
term allow the design of therapeutics improving/acceler-
ating graft recovery and improving transplantation out-
comes.
Methods
Tissue collection
0.5 cm3 biopsies were surgically removed in the course of
34 liver transplantation procedures performed within
McGill University Health Centre with approval of the
institution's ethic committee (ERB 05-003) as previously
described [11,16] and as schematically represented in Fig-
ure 1A. Briefly, ischemic liver biopsies were taken shortly
before the donor liver clamping (I0), and 10 and 60 min
(I10 and I60) after perfusion of the liver with cold organ
preservation solution (Belzer®). Reperfused liver biopsies
were collected during re-implantation in the recipient
patient, just before clamp removal (R0), and respectively
10 and 60 minutes after the blood flow has been re-estab-
lished in the hepatic portal vein (R10 and R60). The aver-
age cold ischemia phase was 8 h 30 ± 2 h 15 whereas the
average warm ischemia time was 48 min ± 26 min.
Protein extraction
Proteins were extracted from each tissue sample by
homogenization and solubilization in phosphate buffer
saline (PBS) added with 1% TX100 1 mM NaF, 1 mM
Na3VO4 and protease inhibitors (Complete®, Roche Diag-
nostics, Laval, QC). Equal protein amounts from 3 inde-
pendent ischemia or reperfusion liver biopsies were
pooled for each time-point to reduce the variability
between individual patients.
Immunoprecipitation
Protein extracts (1 mg) were incubated overnight at 4°C
with mouse monoclonal anti-phosphotyrosine antibod-
ies covalently coupled to agarose beads (PY20, Sigma, St
Louis, MO) or rabbit anti Nck-1 immune serum, kindly
provided by Dr Louise Larose, McGill University, Mon-
treal, QC [31]. Immune complexes were collected follow-
ing incubation with protein G-Sepharose beads (GE
HealthCare, Baie d'Urfé, QC) for 45 min at 4°C. After
three to five washes in PBS, proteins were eluted using
Laemmli sample buffer and resolved by 1D SDS-PAGE
prior to mass spectrometry analysis or immunoblotting.
Mass spectrometry
Following separation of the proteins purified as described
above by 1D SDS-PAGE and Coomassie R-250 staining,
each band was excised, transferred to a 96 wells tray, dehy-
drated with acetonitrile and washed by two cycles of 10
min in 100 mM (NH4)2CO3 before the addition of anProteome Science 2007, 5:1 http://www.proteomesci.com/content/5/1/1
Page 13 of 15
(page number not for citation purposes)
equal volume of acetonitrile. The destained gel slices were
then treated for 30 min with 10 mM dithiothreitol to
reduce cystinyl residues and for 20 min with 55 mM
iodoacetamide to effect alkylation. After an additional
round of (NH4)2CO3 and acetonitrile washes, the slices
were extracted with acetonitrile at 37°C. They were then
incubated with trypsin (6 ng/µl in 50 mM (NH4)2CO3)
for 5 h at 37°C and the peptides were extracted in 1% for-
mic acid/2% acetonitrile followed by two further extrac-
tions with additions of acetonitrile. All treatments were
performed robotically using a MassPrep Workstation
(Micromass, Manchester, UK). All extracts from a given
gel slice were combined in the corresponding well of
another 96 wells tray. This tray was transferred to the
autosampler of a CapLC (Waters, Milford, MA) for mass
spectrometry analysis on a QTOF2 (Micromass, Manches-
ter, UK) upgraded with EPCAS™ (Embedded PC Acquisi-
tion System). A volume of 20 µL of sample was injected at
a flowrate of 30 µL/min with pump C to a µ-Precolumn™
(LC Packings, Amsterdam, NL) filled with C18 Pepmap
100 (300 µm ID × 5 mm, 5 µm, 100 Å) held on a 10 port
Cheminert® valve (VICI Valco Canada, Brockville, ON).
After 5 min of washing, the 10 port valve was actuated so
the acetonitrile gradient from pump A and B eluted the
peptides toward the PicoFrit column (New Objective,
Woburn, MA) filled with BioBasic® C18 stationary phase
(75 µm ID, 10 cm, 5 µm, 300 Å). Gradient solvent was
delivered at a flowrate of 1 µL/min and was splitted to 200
nL/min for the PicoFrit™ column with a splitting tee. Sol-
vent A was water (formic acid 0,1%) and solvent B was
acetonitrile (formic acid 0,1%). The linear gradient was
set from 5% B to 40% in 20 min, from 40% to 70% in 5
min, from 70% to 95% in 5 min, held at 95% for 7 min
and brought back to 5% in 10 min. The PicoFrit™ column
was installed on a nanospray probe so that the spraying
tip was near the sampling cone of the mass spectrometer.
Voltage on the capillary was adjusted to get a nice plume
during elution of peptides. Acquisitions were done in
Data Directed Acquisition mode (DDA) while a 1 second
survey scan was first done from 350 to 1600 m/z. The four
most intense doubly and triply charged ions were selected
to undergo MS/MS fragmentation in 1 second scans from
50 to 2000 m/z. The collision energies were determined
automatically by the instrument based on the m/z values
and charged states of the selected peptides. MS/MS frag-
mentation stopped when the total ion current was lower
than 3 counts or up to a maximum acquisition time of 5
seconds, whatever came first.
Mass spectrometry data processing and analyses
The MS/MS data were peaklisted (ProteinLynx, Micro-
mass, UK) and submitted to a local Mascot database
search software (Matrix Science, UK) for search analysis
against the NCBI mammalian non-redundant database
with a confidence level of 95% or greater. Specific and
shared peptides with an equal or greater score than the
identity score were kept and recorded for each band. Pro-
teins for which at least one specific peptide (i.e. peptide
found specifically in their cognate protein) was identified
with a significant Mascot score in the two replicates were
retained.
Cell fractionation and immunoblotting
Proteins were extracted from each tissue sample by
homogenization in 150 mM KCl, 10 mM Tris-HCl, pH
7.5, 2.5 mM MgOAc, 4 mM imidazole pH 7.4 added with
1 mM NaF, 1 mM Na3VO4 and protease inhibitors (Com-
plete®, Roche Diagnostics, Laval, QC) and pre-cleared.
Insoluble fractions (pellet – P100) were then partitioned
from soluble fraction (supernatant – S100) following cen-
trifugation at 100,000 rpm for 30 min in a TLA-100.2
rotor (Beckman Coulter, Fullerton, CA). Immunoblot
analyses were carried out as described previously [32].
Immunohistochemistry
Liver tissues sections (8 µm thick) on glass slides were
fixed in 3.7% formaldehyde. Tissue sections were peroxi-
dase-immunostained with Nck-1 antibody using the Envi-
sion+® rabbit kit (Dako, Mississauga, ON) according to
the manufacturer's instructions. Sections were then coun-
terstained using hematoxylin (Vector, Burlington, ON)
then dehydrated and mounted using Permount (Fisher,
Nepean, ON).
Nck-1 GST pull-down
BL21 bacteria expressing pGEX-2TK Nck-1 GST [33] were
sonicated 3 × 30 s on ice and lysed in PBS added with 1%
TX100, 1 mM NaF, 1 mM Na3VO4 and protease inhibitors
(Complete®, Roche Diagnostics, Laval, QC) for 30 min on
ice. After 30 min centrifugation at 4°C, fusion proteins
were purified with glutathione-Sepharose beads (GE
HealthCare, Baie d'Urfé, QC) according to manufacturer
instructions. Beads were then incubated with 1 mg of pro-
tein extract pre-cleared with GST as described previously
[34], collected, washed three times with PBS and resus-
pended in Laemmli sample buffer prior protein separa-
tion on 1D SDS-PAGE and mass spectrometry analysis.
Statistical evaluation
Immunoblots analyses were performed on 3 pools of
three livers (9 independent livers) and in two replicates.
Immunostainings were carried out on 6 independent liv-
ers and mass spectrometry analyses were performed on 2
pools of three livers (6 independent livers). Immunoblot
data were analysed and quantified using the FluorChem
software (Alpha Innotech, San Leandro, CA). Data are
expressed as means ± SD (Standard Deviation). Compari-
sons between the 0 time point (control) and the 10 and
60 min time point (treatment) were performed using aProteome Science 2007, 5:1 http://www.proteomesci.com/content/5/1/1
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Wilcoxon signed rank test. A value of p < 0.05 was consid-
ered as significant and marked with an asterisk.
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